Melanoma Clinical Trials in Concord, NC
As of June 2026, 1 paid clinical trial is recruiting for Melanoma in Concord, North Carolina. Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Concord
Filter results
1 clinical trial for Melanoma
·Clear filters·↓ Download CSVAbout research studies in Concord
Concord has approximately 34 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Concord
Researchers run research studies in Concord, NC at 9 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Atrium Health Cabarrus/LCI-Concord | Extensive Stage Lung Small Cell Carcinoma, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Stage III Hypopharyngeal Carcinoma AJCC v8 | 23 |
| Atrium Health Cabarrus | Osteomyelitis Tibia, Tibial Fractures, Articular Fractures | 4 |
| Hawthorne Health NC | Heart Failure, Obesity | 2 |
| Atrium Health | Diabetes, End Stage Renal Disease | 1 |
| Atrium Health Cabarrus (biopsy only) | Urothelial Carcinoma | 1 |
| Levine Cancer Institute | Metastatic Breast Cancer | 1 |
| Levine Cancer Institute Concord | Urothelial Carcinoma | 1 |
| Sanger Heart & Vascular Institute | LE ALI, Lower Extremity Acute Limb Ischemia | 1 |
| Site US10020 | Prostate Cancer | 1 |
Active & Upcoming Studies in Concord (2026)
Recruiting trials in Concord grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (25 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · Phase 2 · NRG Oncology
Diabetes & metabolic (2 active studies)
Cardiovascular (2 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation · Phase 3 · Novo Nordisk A/S
Common conditions studied in Concord
- Extensive Stage Lung Small Cell Carcinoma (3 active studies). Recruiting Extensive Stage Lung Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (2 active studies). Recruiting Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (2 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Osteomyelitis Tibia (2 active studies). Recruiting Osteomyelitis Tibia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage III Hypopharyngeal Carcinoma AJCC v8 (2 active studies). Recruiting Stage III Hypopharyngeal Carcinoma AJCC v8 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage III Laryngeal Cancer AJCC v8 (2 active studies). Recruiting Stage III Laryngeal Cancer AJCC v8 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Concord
- National Cancer Institute (NCI)
- NRG Oncology
- Wake Forest University Health Sciences
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Concord. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Concord
Hipa.ai aggregates every recruiting study in Concord from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Concord?
There are approximately 34 recruiting clinical trials in Concord, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Concord pay participants?
Most recruiting trials in Concord compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Concord?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Concord?
The most common conditions under active study in Concord include Extensive Stage Lung Small Cell Carcinoma (3), Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (2), Heart Failure (2), Osteomyelitis Tibia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Concord?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Concord on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Concord?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Concord?
Recruiting research sites in Concord include Atrium Health Cabarrus/LCI-Concord, Atrium Health Cabarrus, Hawthorne Health NC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Concord right now?
The largest active categories in Concord are Cancer & tumors (25), Diabetes & metabolic (2), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.